Industry must help fund medical cannabis trials, says Lord

Industry must help fund medical cannabis trials, says Lord
Cannabis Health News

The medical cannabis industry needs to invest in clinical trials if products are to be made available on the NHS, says a Conservative Lord. Speaking to the House of Lords on Tuesday 12 July, Conservative Peer, Lord Kamal, said the Medicines and Healthcare Regulatory Authority (MHRA) was “ready to regulate medical cannabis” – but more support was needed from those in the industry. During a debate on medicinal cannabis, Lord Kamal, the parliamentary under-secretary of state for Technology, Innovation and Life Sciences, said cannabis companies must come forward to help fund clinical trials. The Government is said to be “encouraging” producers to work with them to get MHRA approval, but that many were “choosing not to” instead preferring to sell products unlicensed.  The MHRA is responsible for ensuring that new medicines meet applicable standards of safety, quality and efficacy. Once a drug has an MHRA licence, the National Institute for Health and Care Excellence (NICE) can recommend that it be prescribed on the NHS. Lord Kamal said: “We know that there is a barrier because companies have not come forward to have it regulated or go through the clinical trials, but we are trying to work with those companies and encourage them to come forward.  “In fact, we have also found some NIHR research money available to help with those trials. My request to the industry is: ‘You make a lot of money out of this—please come forward and go through those trials with the MHRA’. He added: “The MHRA is ready to regulate medicinal cannabis; it just needs companies to come forward and spend money on the trials.” Members of the House of Lords discussed the blocks to accessing medical cannabis in the UK, following the recent uncertainty over the importation of the privately prescribed product Celixir20. The product,…

Excerpt only …
Source : Industry must help fund medical cannabis trials, says Lord

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.